(Total Views: 624)
Posted On: 04/25/2022 11:51:05 PM
Post# of 154182
So I was reading our little odd FDA warning blurb: Warning Letter from the U.S. Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion in which FDA "asserted" that statements made in a video created a misleading impression regarding the safety and efficacy of leronlimab.
And if you click on the link, it tells you all the "bad" things CytoDyn said in detail, like: “Our critically-ill population that we did in the United States when we gave a dose of leronlimab, the survival rate was 78%. Once we gave them another dose, the survival rate went up to 82%.”
It's very close to click bait. Don't click here, don't click here: https://d1io3yog0oux5.cloudfront.net/cytodyn/...Final_.pdf
Odd how the whole thing is set up and worded.
And if you click on the link, it tells you all the "bad" things CytoDyn said in detail, like: “Our critically-ill population that we did in the United States when we gave a dose of leronlimab, the survival rate was 78%. Once we gave them another dose, the survival rate went up to 82%.”
It's very close to click bait. Don't click here, don't click here: https://d1io3yog0oux5.cloudfront.net/cytodyn/...Final_.pdf
Odd how the whole thing is set up and worded.
(2)
(0)
